A special PET scan for neuroendocrine tumors
Part of Cancer clinical trials.
This study tests a new type of PET scan that uses a special tracer (a radioactive substance) to find neuroendocrine tumors. The scan may help detect these tumors more clearly, which can guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with, or a doctor strongly suspects you have, a neuroendocrine tumor.
- You are able to undergo a biopsy or surgery if the doctor recommends it.
- You do not have another active cancer.
- You do not have serious health problems (like heart or lung disease) that are not well controlled, or an active infection.
- You can understand and sign an informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan using a radioactive tracer called 61Cu-NODAGA-LM3 to detect neuroendocrine tumors (NETs). The goal is to see if it works as well as or better than the standard scan. If you have a NET and need a scan for staging or treatment planning, you might be able to join.
This study tests an imaging scan using a special tracer (68Ga-HA-DOTATATE) to look for tumors that have somatostatin receptors. It may help doctors better locate suspected tumor sites so treatment planning can be more accurate.
This pilot study tests a total-body PET scan with approved tracer medicines to help detect cancer spread in people with suspected metastatic prostate cancer or certain neuroendocrine tumors (NETs). You may be able to join if recent scans already suggest metastasis and you can safely complete the scan timing and positioning.
This trial tests a new PET scan tracer to find neuroendocrine tumors in the body. It may help doctors see where the tumors are and plan better treatment.
This study compares two types of PET/CT scans to see which one is better at finding and staging neuroendocrine tumors. If you qualify, you will get both scans, which may help your doctor plan your treatment more accurately.
This trial tests a new type of PET/CT scan called [68Ga]Ga-FAPI-04 to see if it can better detect high-grade neuroendocrine tumors. It is for patients whose standard scans show low uptake or who have aggressive tumor features.
Hear when a new Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.